ADAM22 FOR USE AS A PROGNOSTIC VARIABLE, AND TARGET FOR THERAPY, OF A METASTATIC BREAST CANCER DISEASE
- Application ID: EP12795354
- Status: █ The patent has been granted
This EP application has the IPC class G01 (MEASURING; TESTING). PurdyLucey is specialized in G01. PurdyLucey is specialised in G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 04.11.2011 - Priority Date (EP 20110187962)
- 10.05.2013 - Publication A1 (WO2013064699)
- 10.09.2014 - Publication A1 (EP2773961)
- 26.07.2017 - Publication B1 (EP2773961)